sb 203580 has been researched along with veratridine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (veratridine) | Trials (veratridine) | Recent Studies (post-2010) (veratridine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,755 | 0 | 86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, T; Maruta, T; Miyazaki, S; Nemoto, T; Satoh, S; Wada, A; Yanagita, T; Yoshikawa, N | 1 |
1 other study(ies) available for sb 203580 and veratridine
| Article | Year |
|---|---|
Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.
Topics: Animals; Calcium; Carbazoles; Cattle; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Growth Cones; Humans; Imidazoles; Ion Channel Gating; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nicotine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C-alpha; Pyridines; Receptors, Nicotinic; Sodium Channels; tau Proteins; Tetrodotoxin; Time Factors; Veratridine | 2010 |